EQL Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is April - March.

Millions SEK. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 23, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Cap	608	1,606	2,064	-	-	-
Market Cap Growth	-77.05%	-22.15%	-	-	-	-
Enterprise Value	980.89	1,968	2,437	0	0	0
Last Close Price	20.60	54.40	71.00	-	-	-
PE Ratio	49.05	129.52	49.31	-	-	-
Forward PE	25.35	29.17	31.21	16.99	-	-
PS Ratio	1.41	3.71	5.52	-	-	-
PB Ratio	2.28	6.02	9.34	-	-	-
P/FCF Ratio	26.54	70.10	-	-	-	-
P/OCF Ratio	21.45	56.64	-	-	-	-
EV/Sales Ratio	2.27	4.55	6.52	-	-	-
EV/EBITDA Ratio	20.15	40.42	36.17	-	-	-
EV/EBIT Ratio	20.15	40.42	36.17	-	-	-
EV/FCF Ratio	42.80	85.88	-	-	-	-
Debt / Equity Ratio	1.68	1.68	2.03	0.67	0.42	0.57
Debt / EBITDA Ratio	9.21	9.21	6.76	3.68	1.61	1.96
Debt / FCF Ratio	19.57	19.57	-	-	2.45	1.85
Net Debt / Equity Ratio	1.35	1.35	1.69	0.56	0.14	0.28
Net Debt / EBITDA Ratio	7.43	7.43	5.54	3.06	0.54	0.90
Net Debt / FCF Ratio	15.78	15.78	-12.13	-8.06	0.82	0.85
Asset Turnover	0.52	0.52	0.63	0.80	0.99	1.86
Inventory Turnover	1.36	1.42	1.53	1.74	2.69	7.47
Quick Ratio	0.97	0.97	0.94	0.50	0.82	0.80
Current Ratio	1.92	1.92	1.81	1.22	1.43	1.25
Return on Equity (ROE)	4.67%	5.14%	21.63%	13.66%	22.21%	29.37%
Return on Assets (ROA)	4.03%	4.04%	9.04%	7.85%	12.53%	15.44%
Return on Invested Capital (ROIC)	5.31%	5.48%	12.26%	11.40%	19.56%	21.96%
Return on Capital Employed (ROCE)	7.61%	7.93%	16.85%	17.16%	26.87%	31.36%
Earnings Yield	2.06%	0.77%	2.03%	-	-	-
FCF Yield	3.77%	1.43%	-	-	-	-
Buyback Yield / Dilution	-0.92%	-0.92%	-0.34%	-0.91%	0.10%	-1.69%
Total Shareholder Return	-0.92%	-0.92%	-0.34%	-0.91%	0.10%	-1.69%